Hostname: page-component-cd9895bd7-8ctnn Total loading time: 0 Render date: 2024-12-25T05:58:33.571Z Has data issue: false hasContentIssue false

Adult ADHD in the Republic of Ireland: the evolving response

Published online by Cambridge University Press:  18 September 2023

Shaeraine Raaj*
Affiliation:
Connolly Hospital, Dublin, Ireland
Margo Wrigley
Affiliation:
Dr Steevens’ Hospital, Dublin, Ireland
Richard Farrelly
Affiliation:
Crumlin General Adult Mental Health Service, Dublin, Ireland
*
Correspondence to Shaeraine Raaj ([email protected])
Rights & Permissions [Opens in a new window]

Abstract

Historically, attention-deficit hyperactivity disorder (ADHD) was conceptualised as a disorder of childhood that gradually improved and diminished as individuals transitioned to adulthood. Over the past decade, several studies have been published describing a cohort of adolescents with a childhood diagnosis of ADHD experiencing a continuity of ADHD symptoms into adulthood. Untreated ADHD in adults is associated with personal relationship difficulties, educational and occupational underachievement, comorbid mental health problems, substance misuse, and increased rates of road traffic accidents and criminality. These result in an increased economic burden and broader public health challenges. This review outlines the current framework and stage of development of ADHD services for adults in the Republic of Ireland.

Type
Review Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution and reproduction, provided the original article is properly cited.
Copyright
Copyright © The Author(s), 2023. Published by Cambridge University Press on behalf of Royal College of Psychiatrists

Situated in north-west Europe, Ireland is a melting pot of cultures. The population increased from 3 million in 1950 to 5 million in 2022, with 1 million people living in Dublin, the capital city. The population of working-age people (between 18 and 65 years old) is estimated to be 3 million.1 The ratio between males and females is 50.1 and 49.1%.1 In the Republic of Ireland, there is increased recognition of adult attention-deficit hyperactivity disorder (ADHD) reported in general practice clinics and community mental health teams (CMHTs).Reference Adamis, O'Neill, Mulligan, O'Mahony, Murthy and McCarthy2,Reference Gavin and McNicholas3 It is reported that about 1.5% of adults in Ireland have ADHD, meaning about 56 000 adults are affected by the condition and meet full diagnostic criteria.Reference Faraone, Biederman and Mick4 The worldwide prevalence of adult ADHD is estimated at 2.8%.Reference Fayyad, Sampson, Hwang, Adamowski, Aguilar-Gaxiola and Al-Hamzawi5

Several policy reforms in the past decade have led to advances in the Irish mental health system, from the initial development of the Mental Health Act 1945 to the more recently implemented Mental Health Act 2001, including legislation, policy, codes of practice and service development to improve Ireland's mental health service delivery. However, there is an opportunity for further service organisational development to improve mental healthcare delivery in the Republic of Ireland in line with government policy as outlined in Sharing the Vision.6

This review aims to outline the work in progress on developing adult ADHD services in accordance with the Health Service Executive (HSE) National Clinical Programme (NCP) for ADHD in adults and to also provide recommendations on training of psychiatrists.

ADHD

ADHD is a common neurodevelopmental condition, the clinical characteristics of which include persistent hyperactivity, inattention and impulsivity resulting in significant psychosocial and other impairments.Reference Katzman, Bilkey, Chokka, Fallu and Klassen7 Historically, ADHD was first diagnosed and treated during childhood; however, recent studies recognise that the core symptoms persist into adulthood in a significant proportion of individuals.Reference Song, Zha, Yang, Zhang, Li and Rudan8 The diagnosis is recognised by the American Psychiatric Association and World Health Organization.Reference Lovett and Harrison9

The worldwide prevalence of childhood ADHD is estimated at 5%,Reference Sayal, Prasad, Daley, Ford and Coghill10 and approximately 80% of children with the combined type of presentation continue to have persistent symptoms into early adulthood and meet the full diagnostic criteria.Reference van Lieshout, Luman, Twisk, van Ewijk, Groenman and Thissen11 Compared with the childhood phase, the core symptoms of ADHD that progress to adulthood are predominantly inattentiveness and mild hyperactive–impulsive behaviour.Reference Lee, Kim, Kim, Malcolm, Kuo and Bird12,Reference Thorell, Holst and Sjöwall13 Inattentiveness in the adult cohort is described as difficulty sustaining attention or completing a task initiated, being easily distracted, and forgetting items and appointments.Reference Thorell, Holst and Sjöwall13 Hyperactive-impulsive symptoms range from fidgeting a lot, difficulty remaining seated, restlessness, often talking excessively and ‘being very much on the go’.Reference Franke, Michelini, Asherson, Banaschewski, Bilbow and Buitelaar14 The features of ADHD are common in the general population, but when they are persistent and pervasive and cause problems for an individual, then a diagnosis should be considered. Functional impairment in two or more domains (social and personal relationships, education and/or occupation, and coping with everyday activities) is required to make a diagnosis in line with DSM-5 criteria.15

ADHD in adults is underdiagnosed in most countries, adversely affecting individuals’ overall quality of life, including increased psychological distress, academic decline, loss of employment, and increased family and economic burden.Reference Katzman, Bilkey, Chokka, Fallu and Klassen7,Reference Sayal, Prasad, Daley, Ford and Coghill10 According to a study published in 2022, people with ADHD have lower life expectancy.Reference Schiavone, Virta and Leppämäki16 Eighty per cent of adults with ADHD have at least one psychiatric comorbidity, such as depressive illness, bipolar affective disorder, anxiety disorder, sleep disorder, substance use disorder, obsessive–compulsive disorder, post-traumatic stress disorder, somatoform disorder or personality disorders.Reference Katzman, Bilkey, Chokka, Fallu and Klassen7,Reference Andersson, Lauvsnes and Nordfjærn17Reference Park, Cho, Chang, Jeon, Cho and Kim19 Given that parenting involves patience, attention, problem-solving and planning, a parent who is experiencing symptoms of ADHD may have marked difficulty with parenting.Reference Mokrova, O'Brien, Calkins and Keane20 Parents with ADHD symptoms are reported to be more inconsistent with discipline and lack supportiveness with respect to children's emotions.Reference Mokrova, O'Brien, Calkins and Keane20

Accidental death is more common among those with ADHD than those without ADHD (13.2% v. 4.3%, P = 0.052).Reference London and Landes21 The Swedish national registration data reported an increased in road traffic accidents and death secondary to undiagnosed and untreated ADHD.Reference Chang, D'Onofrio, Quinn, Lichtenstein and Larsson22 A meta-analysis in 2018 examined 32 studies and concluded that those with untreated ADHD had a 40−50% greater risk of road traffic accident injuries.Reference Ruiz-Goikoetxea, Cortese, Magallon, Aznárez-Sanado, Zallo and Luis23 Adults with ADHD have a high prevalence of comorbidities including drug and alcohol misuse.Reference Grazioli, Gmel, Rougemont-Bücking, Baggio, Daeppen and Studer24

Recent research on ADHD in the prison population suggests an estimated prevalence rate of between 17 and 30% of offenders in prison meeting the diagnostic criteria for adult ADHD.Reference Grazioli, Gmel, Rougemont-Bücking, Baggio, Daeppen and Studer24Reference Beaudry, Yu, Långström and Fazel26 Young and colleagues reported that nearly 25% of prisoners have ADHD, many undiagnosed or untreated.Reference Young, Gudjonsson and Chitsabesan27 Some studies have reported that there is a possibility of treating people with ADHD to reduce impulsive behaviour and subsequently reduce potential involvement with crime and reoffending.Reference Beaudry, Yu, Långström and Fazel26,Reference Young, Gudjonsson and Chitsabesan27 It is reported that prisoners with a diagnosis of ADHD are often not treated with oral medication because of uncertainty over the reliability and validity of the ADHD diagnosis and concerns regarding potential drug misuse.Reference Beaudry, Yu, Långström and Fazel26Reference Asherson, Johansson, Holland, Fahy, Forester and Howitt28

Adult ADHD in the Republic of Ireland

In Ireland, there is increased reporting of adult ADHD as a diagnosis in general practice CMHTs.Reference Adamis, O'Neill, Mulligan, O'Mahony, Murthy and McCarthy2,Reference Gavin and McNicholas3 Approximately 15% of working-age adults attending general adult CMHTs may have ADHD that is currently undiagnosed.Reference Adamis, Fox, de M de Camargo, Saleem, Gavin and McNicholas29 Before the development of the NCP, there were no adult-specific ADHD public services available in Ireland providing assessment and treatment for ADHD in adults.30 In 2017, the HSE, which provides all public health services in Ireland, recognised this as a deficit and established a working group to develop a model of care for adults with ADHD. The working group included representation from ADHD Ireland, a voluntary organisation established in 1980 to provide information, resources and networking opportunities to individuals and families with ADHD. In January 2021, this NCP for adult ADHD in Ireland was formally launched by the Minister of State for Mental Health and Older People.30 The programme, through a multidisciplinary working group with service user representation and chaired by a clinical lead, developed a model of care covering core values and guiding principles, assessment and treatment of ADHD in line with National Institute of Health and Care Excellence (NICE) guidelines,31 service organisation including governance structures, the resources required, and education and training.

NCP for adult ADHD in the Republic of Ireland

The NCP for adult ADHD recommends the development of 11 adult ADHD clinics in line with the National Model of Care to provide assessment and multi-modal treatment.30 The recommendation is for each adult ADHD clinic to be led by a consultant psychiatrist and have a multidisciplinary team consisting of a senior psychologist, senior occupational therapist, clinical nurse specialist and administrator.30 The public adult ADHD clinics would provide services to adults over 18 years old and accept referrals from general adult and child CMHTs.30

The development of adult ADHD clinics depends on additional funding for full implementation. Following its launch, 1.3 million euros was provided by the Department of Health to establish three pilot services. The clinical lead was asked to oversee and support the implementation of the programme nationally. The three pilot services were set up in 2022 and are now operational. These pilot services cover the following areas in Ireland:

  • CHO 1: Sligo, Leitrim and Donegal

  • CHO 3: Limerick, Clare and North Tipperary

  • CHO 6: Dun Laoghaire, Dublin South East and Wicklow (North and South).

The 2022 Estimates Process funded a further four ADHD teams.30 Two teams are now operational, with the third due to start in summer 2023. Recruitment is ongoing for the fourth team. These sites are:

  • CHO 4: Cork (North Lee, South Lee and North Cork) – now operational

  • CHO 4: Kerry and West Cork – now operational

  • CHO 7: Dublin South City, Dublin South West and Dublin West

  • CHO 8: Midland counties (Laois, Offaly, Longford, Westmeath, Kildare and West Wicklow).

The national model of care for adult ADHD provides a clinical pathway including the referral procedure. The first step is for a general practitioner to refer a patient to their local general adult CMHT to be assessed for comorbid mental illness and screened for adult ADHD. Where clinical findings suggest a potential diagnosis of adult ADHD, the general adult CMHT refers the patient to the ADHD adult clinic for further assessment and management.30 The advantage of this cohort of patients being assessed at the secondary care level (CMHT) is that it ensures any significant mental health problems are identified and treated before the patient is referred to a tertiary-level adult ADHD clinic. The referral pathway for young people transitioning from child and adolescent mental health services (CAMHS) is modified to provide direct access from CAMHS to an adult ADHD service where ADHD is the primary problem.

This model of care ensures that adults with a potential diagnosis of ADHD can access a specialist multidisciplinary service providing an integrated, person-centred and evidence-based multi-modal response in accordance with NICE guidelines.31 The model includes ADHD-specific medication and non-pharmacological interventions, both group and individual. The focus is on enabling people with ADHD to manage their symptoms and develop strategies to do so, with a view to discharge within a 6−12 month period in line with the ethos of enablement.

Built into the implementation of the adult ADHD NCP is an evaluation of the three pilot sites. This is being undertaken by the University College Dublin School of Psychology over a 2 year period. It will examine the referral rate, the proportion in whom ADHD is confirmed, the demographic and psychosocial attributes of those with ADHD, interventions provided, outcomes and patient feedback on the service received. In addition, there is a second arm looking specifically at the impact of the service model on adult mental health services. The results of the evaluation will be considered, and adjustments to the model of care will be made where indicated.

The NCP and integrated care

In line with the Sláintecare principles of integrated care for Ireland's national health service policy,32 the NCP has from the start worked in partnership with the voluntary sector, specifically ADHD Ireland, and with an academic partner, UCD School of Psychology. A number of projects have been completed to advocate for services for people with ADHD and to augment current public service provision. The former include a study on suicidality and repeated self-harming in people with ADHD in Ireland,Reference Bramham, Seery, Murphy, Kilbride, O'Riordan and Wrigely33 and ongoing studies are in progress on ADHD in third-level students, ADHD in women and the psychosocial impacts of ADHD in adults, all focused on Ireland. The two service augmentations are an app on adult ADHD, which can be downloaded from both Apple and Google app stores, and the Understanding and Managing Adult ADHD Programme. This is a 6 week online workshop offering psychoeducation and is based on acceptance and compassion therapy. It is funded by the HSE, delivered through ADHD Ireland and led by a senior psychologist who has ADHD. Both of these initiatives are currently being formally evaluated.

In line with experience elsewhere, there is a surge of people seeking assessment for ADHD post pandemic.Reference Rogers and MacLean34 This can be attributed to several factors, including symptoms of ADHD being uncovered by the isolation and consequent loss of the supportive structure of work or college when working or studying at home, together with a greater public awareness of the condition. Asherson and colleagues recommended the development of an ADHD specialism within primary care, including the transfer of routine assessment, treatment and monitoring of treatment in line with NICE guidelines.Reference Asherson, Leaver and Adamou35 This approach is currently being considered by the NCP in the context of other primary care initiatives for neurodevelopmental disorders in Ireland.

Training of psychiatrists in ADHD in adults in Ireland

The College of Psychiatrists of Ireland (COPI) is the body recognised by the Irish Medical Council for the provision of postgraduate education in psychiatry and for the professional development of consultant psychiatrists. Whereas the assessment and treatment of ADHD is a required competency to complete training in child and adolescent psychiatry and learning disability psychiatry, it is not required for general adult psychiatry or psychiatry of old age. For this reason, the NCP has sourced training from the UK Adult ADHD Network (UKAAN) for psychiatrists, together with all other disciplines recruited to the new adult ADHD services. Furthermore, in consultation with the educational section of COPI, it secured funding to offer UKAAN training to senior registrars in psychiatry in 2020 and both senior registrars and some adult psychiatrists in 2023. Where adult ADHD services have been established, consultants offer special-interest sessions to senior registrars, and the College has approved one full-time senior registrar post in adult ADHD. The HSE, in partnership with COPI, has introduced an ASPIRE/Post CSCST Fellowship in Adult ADHD to provide the opportunity to doctors who have completed higher specialist training in psychiatry to subspecialise in adult ADHD. Trainees can also access an e-module on adult ADHD developed in 2022 by COPI.

With the expansion of adult ADHD services in Ireland, it is hoped that COPI will be able to include the assessment and treatment of ADHD in adults in the list of required competencies to complete training in general adult and old age psychiatry.

Conclusions

Until very recently, there were no public services for adults with ADHD in Ireland. The HSE's decision to design and subsequently launch an NCP to address this significant service deficit has been a major first step in addressing this need. The provision of funding for three services in early 2021 and a further four in 2022, of which six are now operational, is an indication of significant progress. Further funding has been requested to ensure national availability. Ongoing evaluation of the programme with modification of the model of care as indicated is being undertaken. The necessity to expand in primary care in line with international experience of an unprecedented surge in referrals is also under consideration. The training of psychiatrists in this clinical area is essential, and the eventual aim is the ability to deliver this training within Ireland to all postgraduate trainees as a required competency.

About the authors

Shaeraine Raaj is a consultant in the Department of Psychiatry, Connolly Hospital, Dublin, Ireland. Margo Wrigley is clinical lead of the Adult ADHD National Clinical Programme, Dr Steevens’ Hospital, Dublin, Ireland. Richard Farrelly is a consultant psychiatrist at Crumlin General Adult Mental Health Service, Dublin, Ireland.

Author contributions

S.R. and R.F. contributed to the manuscript, and S.R., M.W. and R.F. collaborated to make changes to it in response to the reviewers’ comments. S.R. developed the idea for the study.

Funding

This research received no specific grant from any funding agency, commercial or not-for-profit sectors.

Declaration of interest

None.

References

Ireland Population. Available from: https://countrymeters.info/en/IrelandGoogle Scholar
Adamis, D, O'Neill, D, Mulligan, O, O'Mahony, E, Murthy, S, McCarthy, G, et al. Prevalence of ADHD in adult psychiatric outpatient clinics in Sligo/Leitrim area, Ireland. Eur Psychiatry 2016; 33(S1): S445–6.CrossRefGoogle Scholar
Gavin, B, McNicholas, F. ADHD: science, stigma and service implications. Ir J Psychol Med 2018; 35(3): 169–72.CrossRefGoogle ScholarPubMed
Faraone, SV, Biederman, J, Mick, E. The age-dependent decline of attention deficit hyperactivity disorder: a meta-analysis of follow-up studies. Psychol Med 2006; 36: 159–65.CrossRefGoogle ScholarPubMed
Fayyad, J, Sampson, NA, Hwang, I, Adamowski, T, Aguilar-Gaxiola, S, Al-Hamzawi, A, et al. The descriptive epidemiology of DSM-IV adult ADHD in the World Health Organization World Mental Health Surveys. Atten Def Hyp Disord 2017; 9(1): 4765.CrossRefGoogle ScholarPubMed
Department of Health. Sharing the Vision: A Mental Health Policy for Everyone. Department of Health, 2020 (https://www.gov.ie/en/publication/2e46f-sharing-the-vision-a-mental-health-policy-for-everyone/).Google Scholar
Katzman, MA, Bilkey, TS, Chokka, PR, Fallu, A, Klassen, LJ. Adult ADHD and comorbid disorders: clinical implications of a dimensional approach. BMC Psychiatry 2017; 17(1): 302.CrossRefGoogle ScholarPubMed
Song, P, Zha, M, Yang, Q, Zhang, Y, Li, X, Rudan, I. The prevalence of adult attention-deficit hyperactivity disorder: a global systematic review and meta-analysis. J Glob Health 2021; 11: 04009.CrossRefGoogle ScholarPubMed
Lovett, BJ, Harrison, AG. Assessing adult ADHD: new research and perspectives. J Clin Exp Neuropsychol 2021; 43(4): 333–9.CrossRefGoogle Scholar
Sayal, K, Prasad, V, Daley, D, Ford, T, Coghill, D. ADHD in children and young people: prevalence, care pathways, and service provision. Lancet Psychiatry 2018; 5(2): 175–86.CrossRefGoogle Scholar
van Lieshout, M, Luman, M, Twisk, JW, van Ewijk, H, Groenman, AP, Thissen, AJ, et al. A 6-year follow-up of a large European cohort of children with attention-deficit/hyperactivity disorder-combined subtype: outcomes in late adolescence and young adulthood. Eur Child Adolesc Psychiatry 2016; 25(9): 1007–17.CrossRefGoogle ScholarPubMed
Lee, KC, Kim, E, Kim, J, Malcolm, B, Kuo, GM, Bird, A, et al. Development of an innovative adult attention-deficit hyperactivity disorder clinic. Ment Health Clin 2020; 10(5): 296300.CrossRefGoogle ScholarPubMed
Thorell, LB, Holst, Y, Sjöwall, D. Quality of life in older adults with ADHD: links to ADHD symptom levels and executive functioning deficits. Nord J Psychiatry 2019; 73(7): 409–16.CrossRefGoogle ScholarPubMed
Franke, B, Michelini, G, Asherson, P, Banaschewski, T, Bilbow, A, Buitelaar, JK, et al. Live fast, die young? A review on the developmental trajectories of ADHD across the lifespan. Eur Neuropsychopharmacol 2018; 28(10): 1059–88.CrossRefGoogle Scholar
American Psychiatric Association. American Psychiatric Association: Diagnostic and Statitical Manual Mental Disorder: 22209–3901 (5th edn). APA, 2013.Google Scholar
Schiavone, N, Virta, M, Leppämäki, S, Launes J, Vanninen R, Tuulio-Henriksson A, et al. Mortality in individuals with childhood ADHD or subthreshold symptoms – a prospective perinatal risk cohort study over 40 years. BMC Psychiatry 2022; 22: 325.CrossRefGoogle ScholarPubMed
Andersson, HW, Lauvsnes, A, Nordfjærn, T. Emerging adults in inpatient substance use treatment: a prospective cohort study of patient characteristics and treatment outcomes. Eur Addict Res 2021; 27(3): 206–15.CrossRefGoogle ScholarPubMed
Kooij, JJ, Huss, M, Asherson, P, Akehurst, R, Beusterien, K, French, A, et al. Distinguishing comorbidity and successful management of adult ADHD. J Atten Disord 2012; 16(5 Suppl): 3S19S.CrossRefGoogle ScholarPubMed
Park, S, Cho, MJ, Chang, SM, Jeon, HJ, Cho, SJ, Kim, BS, et al. Prevalence, correlates, and comorbidities of adult ADHD symptoms in Korea: results of the Korean epidemiologic catchment area study. Psychiatry Res 2011; 186(2–3): 378–83.CrossRefGoogle ScholarPubMed
Mokrova, I, O'Brien, M, Calkins, S, Keane, S. Parental ADHD symptomology and ineffective parenting: the connecting link of home chaos. Parent Sci Pract 2010; 10(2): 119–35.CrossRefGoogle ScholarPubMed
London, AS, Landes, SD. Attention deficit hyperactivity disorder and adult mortality. Prev Med 2016; 90: 810.CrossRefGoogle ScholarPubMed
Chang, Z, D'Onofrio, BM, Quinn, PD, Lichtenstein, P, Larsson, H. Medication for attention-deficit/hyperactivity disorder and risk for depression: a nationwide longitudinal cohort study. Biol Psychiatry 2016; 80(12): 916–22.CrossRefGoogle ScholarPubMed
Ruiz-Goikoetxea, M, Cortese, S, Magallon, S, Aznárez-Sanado, M, Zallo, , Luis, EO, et al. Risk of poisoning in children and adolescents with ADHD: a systematic review and meta-analysis. Sci Rep 2018; 8(1): 7584.CrossRefGoogle ScholarPubMed
Grazioli, VS, Gmel, G, Rougemont-Bücking, A, Baggio, S, Daeppen, JB, Studer, J. Attention deficit hyperactivity disorder and future alcohol outcomes: examining the roles of coping and enhancement drinking motives among young men. PLoS One 2019; 14(6): e0218469.CrossRefGoogle ScholarPubMed
Young, S, Moss, D, Sedgwick, O, Fridman, M, Hodgkins, P. A meta-analysis of the prevalence of attention deficit hyperactivity disorder in incarcerated populations. Psychol Med 2015; 45(2): 247–58.CrossRefGoogle ScholarPubMed
Beaudry, G, Yu, R, Långström, N, Fazel, S. An updated systematic review and meta-regression analysis: mental disorders among adolescents in juvenile detention and correctional facilities. J Am Acad Child Adolesc Psychiatry 2021; 60(1): 4660.CrossRefGoogle ScholarPubMed
Young, S, Gudjonsson, G, Chitsabesan, P, Colley B, Farrag E, Forrester A, et al. Identification and treatment of offenders with attention-deficit/hyperactivity disorder in the prison population: a practical approach based upon expert consensus.BMC Psychiatry 2018; 18: 281.CrossRefGoogle ScholarPubMed
Asherson, P, Johansson, L, Holland, R, Fahy, T, Forester, A, Howitt, S, et al. Randomised controlled trial of the short-term effects of OROS-methylphenidate on ADHD symptoms and behavioural outcomes in young male prisoners with attention-deficit/hyperactivity disorder (CIAO-II). Trials 2019; 20(1): 663.CrossRefGoogle ScholarPubMed
Adamis, D, Fox, N, de M de Camargo, APP, Saleem, F, Gavin, B, McNicholas, F. Prevalence of attention deficit hyperactivity disorder in an adult mental health service in the Republic of Ireland. Int J Psychiatry Med 2023; 58(2): 130–44.CrossRefGoogle Scholar
Health Service Executive Ireland. ADHD in Adults. HSE, 2021 (https://www.hse.ie/eng/about/who/cspd/ncps/mental-health/adhd/).Google Scholar
National Institute of Health and Care Excellence. Attention Deficit Hyperactivity Disorder: Diagnosis and Management. NICE, 2018. Available from: https://www.nice.org.uk/guidance/ng87.Google Scholar
Department of Health. Right Care, Right Place, Right Time - Enhanced Community Care. Department of Health, 2021 (https://www.gov.ie/en/publication/14cc1-right-care-right-place-right-time-enhanced-community-care/).Google Scholar
Bramham, J, Seery, C, Murphy, R, Kilbride, K, O'Riordan, F, Wrigely, M. An investigation of suicidal behaviour and self-harm in adults with ADHD in Ireland. Grant Scheme for Collaborative Research Projects Report. HSE National Office for Suicide Prevention, 2023.Google Scholar
Rogers, MA, MacLean, J. ADHD symptoms increased during the COVID-19 pandemic: a meta-analysis. J Atten Disord 2023; 27(8): 800–11.CrossRefGoogle ScholarPubMed
Asherson, P, Leaver, L, Adamou, M, Arif M, Askey G, Butler M, et al. Mainstreaming adult ADHD into primary care in the UK: guidance, practice, and best practice recommendations.BMC Psychiatry 2022; 22: 640.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.